Judy Lieberman, Harvard Medical School to Keynote at Non-Coding RNA & RNAi Therapeutics

Judy Lieberman, Professor of Pediatrics at Harvard Medical School, will give a keynote presentation at GTCbio’s 7th Non-Coding RNA & RNAi Therapeutics Conference.

Judy Lieberman, Professor of Pediatrics at Harvard Medical School, will give a keynote presentation on, “The Silent Treatment: Harnessing RNA Interference for Therapy” at GTCbio’s 7th Non-Coding RNA & RNAi Therapeutics Conference to be held on September 14-15, 2016 in Boston, MA.

Dr. Lieberman’s presentation will review the current status of development of siRNA-based drugs. She will also discuss strategies for targeted gene knockdown that use RNA aptamers or antibodies for selectively delivering siRNAs into cells outside the liver.

The conference will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues in the RNA research field.
Emerging areas in RNA research provide great insight into promising therapeutic tools. Delivery has remained a solid focus for understanding how RNA has proven to play a vital and central role in all cellular function. Advances in cell selective delivery and the target abilities of RNAi demonstrate growth and maturity in the field. The excitement and interest that CRISPR brings continues to progress the evolution of genome editing tools. We will also dive into application of aptamers in diagnostic and therapeutic settings. This will include stability, affinity and specificity of oligonucleotide aptamer ligands and other delivery approaches as well.

This meeting will create space for researchers to learn about the latest discoveries in the field, as well as share and discuss perspectives during networking sessions.

Session topics include:

I. CRISPR Mediated Genome Editing and Functional Screening
II. Emerging Applications for Non-Coding RNAs in Basic and Clinical Research
III. Therapeutic Delivery of Nucleic Acid-Based Drugs
IV. Advances in RNAi, Antisense, and Non-Coding RNA-Based Drugs in Clinical Development

For more information, please visit website:

635 W. Foothill Blvd
Monrovia, CA 91016
Email: infogtcbio@gtcbio.com
Phone: (626) 256-6405
Fax: (626) 466-4433

Contact Details

Company Name: GTCbio
Issued By: Kristen Starkey
Phone: 6262566405
Address: 635 W. Foothill Blvd
City: Monrovia
State: California
Zip: 91016
Country: United States
Website: Visit the website

Keywords : RNA, RNAi, CRISPR,

by Kristen Starkey (few years ago!)

Latest Press Releases

The Mad Hatter Now Offer a Full Line of Hearth Products and Full Line of Grills

Diabetes Insulin Delivery Pens Market Research Report 2018

Dr Kapadia Provides Tips to Patients Interested in Hair Transplant Procedures

love vashikaran specialist

Solar Blanket Sales Market Report 2018

Spring Bottled Water Market Insights, Forecast to 2025

Biochemical Incubator Sales Market Report 2018

Quinine Sulphate Sales Market Report 2018

Automotive Chassisc System Market Insights, Forecast to 2025

2,6-Dicarboxypyridine market size in key regions like North America, Europe, Asia Pacific an..

Remove this press release ?

Due to extra work required to remove the press-releases we have started charging $1.99 for press release removal.

Your press release will be removed in 24 hours, once the payment has been received.

Search Press Release
e.g. Business, Computer, etc.